Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Go back to Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
(NASDAQ: DFTX) Delayed: 38.81 +0.13 (0.34%)
Previous Close $38.68    52 Week High
Open $38.67    52 Week Low
Day High $39.04    P/E N/A 
Day Low $38.10    EPS
Volume 3,215,195